Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Moelis & Company (NYSE: MC) SEC filings, giving investors structured access to the firm’s regulatory disclosures as a global independent investment bank in the investment banking and securities dealing industry. Filings such as Form 8-K, Form 10-K, Form 10-Q, and Form 4 provide insight into Moelis & Company’s financial performance, governance, and insider activity.
Moelis & Company uses Current Reports on Form 8-K to announce material events, including quarterly financial results and board changes. For example, the company files 8-Ks when it releases earnings for specific quarters and when its Board elects a new independent director, detailing items such as results of operations, updated investor presentations, and director compensation arrangements.
Investors can look to the firm’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) for more comprehensive information on revenues, expenses, net income, segment drivers, and risk factors. Moelis & Company also discusses its use of Adjusted (non-GAAP) metrics in conjunction with GAAP results, and its filings reference the ownership structure of Moelis & Company Group LP and related tax treatment.
In addition, Form 4 insider transaction reports, when present, can help users track purchases, sales, and equity awards involving Moelis & Company’s directors and executive officers. Proxy-related filings may further describe board composition, director independence, and compensation practices, as illustrated by the firm’s disclosure of compensation for an independent director in a Form 8-K.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, explain complex sections in simpler language, and surface notable items such as changes in revenues, margins, dividends, or governance. With real-time updates from EDGAR and organized access to 10-Ks, 10-Qs, 8-Ks, and Form 4s, this page helps users quickly understand what Moelis & Company is reporting to regulators and how those disclosures relate to its advisory-focused business model.
Osamu Watanabe, General Counsel and Secretary of Moelis & Co (MC), reported receipt of dividend-equivalent Restricted Stock Units (RSUs) on 09/18/2025. The Form 4 shows Incentive RSUs issued as dividend equivalents tied to prior unvested grants from 2020 through 2025 and that each dividend-equivalent RSU will vest with its underlying award. Reported per-grant resulting beneficial ownership figures following the issuance include 2,202.52, 4,154.56, 5,941.42, 6,272.53, and 6,508.04 shares of Class A common stock. The form is signed by Mr. Watanabe on 09/19/2025.
Eric Cantor, Vice Chairman and Director of Moelis & Co (MC), received dividend-equivalent Restricted Stock Units (RSUs) that increased his beneficial ownership on 09/18/2025. The Form 4 shows grant-like entries for dividend-equivalent Incentive RSUs tied to prior award years 2020 through 2024 and for 2024 Long Term Incentive RSUs. Reported incremental amounts include 60.74, 114.54, 215.48, 221.02, 130.81 and 54.5 units respectively, with resulting beneficial ownership totals shown as 7,325.74, 13,815.16, 25,990.31, 26,658.28, 15,777.26 and 6,573 for each corresponding award line. Each RSU represents the right to receive either a share of Class A common stock or cash equal to its fair market value, and the dividend-equivalent RSUs will vest concurrent with the underlying unvested awards.
Thorold Barker, a director of Moelis & Co (MC), received 2025 Annual Restricted Stock Units totaling 1,614.38 units on 09/18/2025. The Form 4 shows these RSUs were issued as dividend equivalents on underlying Annual RSUs granted July 14, 2025, and will vest concurrently with those underlying awards. Each RSU represents the right to receive one share of Class A common stock. The reported grant lists a price of $13.38 and the filing was signed by an attorney-in-fact on 09/19/2025.
Christopher Callesano, Chief Financial Officer of Moelis & Co (MC), reported issuances of dividend-equivalent Restricted Stock Units (RSUs) on 09/18/2025. The Form 4 shows dividend-equivalent Incentive RSUs credited for multiple grant vintages: 2020 (3.65 RSUs; 439.7 shares held after), 2021 (6.3 RSUs; 760.36), 2022 (14.9 RSUs; 1,797.35), 2023 (13.65 RSUs; 1,646.33), and 2024 (13.62 RSUs; 1,642.48). Each RSU represents the right to receive either one share of Class A common stock or a cash amount equal to the fair market value on settlement. The entries are reported as acquisitions (code A) with a reported price of $0, and the dividend-equivalent RSUs vest concurrently with the underlying unvested Incentive RSUs.
Moelis & Co (MC) director Louise Mirrer reported receipt of restricted stock units (RSUs) on 09/18/2025. The Form 4 lists three non-derivative RSU entries: 1,253.3, 38.76, and 1,695.05 RSUs, each identified as dividend-equivalent RSUs that will vest concurrently with their underlying annual RSUs. The filing was executed by an attorney-in-fact and signed 09/19/2025. No option exercises or derivative transactions are reported. The Form 4 reflects additional equity compensation issued to a director rather than cash transactions or disposals.
Moelis & Co (MC) director Laila Worrell reported acquisitions of restricted stock units on 09/18/2025. The Form 4 shows three separate awards of dividend-equivalent RSUs tied to previously granted awards: 2024 Annual RSUs, 2025 Annual RSUs and 2025 Elective RSUs. Each RSU represents the right to receive one share of Class A common stock and the dividend-equivalent RSUs will vest concurrently with the underlying RSUs. The Form is signed by an attorney-in-fact on 09/19/2025.
Moelis & Company (MC) insider report: Katherine Pilcher Ciafone, listed as Chief Operating Officer, received dividend-equivalent Restricted Stock Units (RSUs) that settle into Class A common stock or cash at the company's option. Transactions dated 09/18/2025 show additions to three incentive RSU grants: 2020 Incentive RSUs (1,465.68 underlying shares), 2021 Incentive RSUs (2,784.01 underlying shares) and 2022 Incentive RSUs (5,941.42 underlying shares). Each grant is reported with a $0 acquisition price, reflecting issuance as dividend equivalents that will vest concurrently with the underlying unvested awards. The form is signed by an attorney-in-fact on 09/19/2025.
Kenneth Shropshire, a director of Moelis & Co (MC), reported a sale of Class A common stock on 08/22/2025. He sold 2,615 shares at a price of $72.52 per share and, following the transaction, beneficially owned 7,109 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
Form 144 filed for Moelis & Company (MC) reports a proposed sale of 2,615 common shares, to be executed on 08/22/2025 through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $189,639.80. The shares represent restricted stock acquired from the issuer on 07/03/2023 and were paid in full on that date. The filing shows 78,502,449 shares outstanding. Key identifying fields for the filer and issuer (CIK, names, contact details) are not populated in the provided content, leaving the selling person's identity and the filer contact information unspecified.
Kayne Anderson Rudnick Investment Management, LLC disclosed beneficial ownership of 6,739,477 Moelis & Co. Class A shares, representing 9.1% of the class. The filing breaks down the firm's control: sole voting power over 4,785,038 shares, shared voting power over 1,358,173 shares, sole dispositive power over 5,381,304 shares and shared dispositive power over 1,358,173 shares. The statement also certifies these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The disclosure clarifies the size and nature of a material, long position in Moelis & Co.